THANK YOU FOR SUBSCRIBING
Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.
“This partnership significantly broadens our global reach and allows us to expand our data set for predictable intelligence-based patient recruitment and retention to support traditional and decentralized trials,” said Lollo Eriksson, CEO of Trialbee. “This is a great opportunity for both organizations to make trials simpler for investigators and to deliver on our commitment of expediting clinical research by optimizing the use of real-world data.”
More than eighty percent of trials are delayed and approximately thirty percent of sites never enroll patients because of limited access to patients who match the study criteria. The combination of Clinerion’s expertise in leveraging real-time, real-patient, and real-world electronic health record (EHR) data for clinical research combined with Trialbee’s unique multiple step qualification process, which includes online qualification and nurse practitioner interviews to ensure high-quality patient matches prior to obtaining consent and enrollment, will significantly improve and streamline this process. The Trialbee platform provides full transparency of the status of the referred patient flow throughout the entire clinical trial and continuously offers sites and sponsors full insight into the effectiveness of recruitment strategies.
“Patients are at the center of everything Clinerion does, and this partnership will ensure better outcomes for patients,” says Ian Rentsch, CEO of Clinerion. “Together, we will be able to match more of the right patients to the leading-edge trials that can bring them the care they need. And, ultimately, our improvement of the efficiency of recruitment for clinical trials will accelerate the introduction of new medicines and interventions.”